PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
PSTX
Delisted
PSTX was delisted on the 7th of January, 2025.
95 hedge funds and large institutions have $153M invested in Poseida Therapeutics, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 36 increasing their positions, 21 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1% less capital invested
Capital invested by funds: $155M → $153M (-$1.55M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
95
Holding in Top 10
1
Calls
$1.22M
Puts
$88K
Top Buyers
| 1 | +$4.44M | |
| 2 | +$1.37M | |
| 3 | +$1.23M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$1M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$779K |
Top Sellers
| 1 | -$7.08M | |
| 2 | -$2.15M | |
| 3 | -$1.16M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$330K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$286K |